These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30898394)

  • 1. The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.
    Stafman LL; Waldrop MG; Williams AP; Aye JM; Stewart JE; Mroczek-Musulman E; Yoon KJ; Whelan K; Beierle EA
    J Pediatr Surg; 2019 Jun; 54(6):1206-1213. PubMed ID: 30898394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells.
    Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Markert HR; Easlick JL; Stewart JE; Crossman DK; Mroczek-Musulman E; Beierle EA
    Cancer Gene Ther; 2022 May; 29(5):558-572. PubMed ID: 33864024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr4.
    Marayati R; Julson J; Bownes LV; Quinn CH; Stafman LL; Beierle AM; Markert HR; Hutchins SC; Stewart JE; Crossman DK; Hjelmeland AB; Mroczek-Musulman E; Beierle EA
    Clin Exp Metastasis; 2022 Dec; 39(6):899-912. PubMed ID: 36315303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA SNHG1 Accelerates Cell Proliferation, Migration, and Invasion of Hepatoblastoma Through Mediating miR-6838-5p/PIM3/RhoA Axis.
    Zhang T; Ji C; Zhang Y; Yuan M; Gao H; Yin Q
    Biochem Genet; 2024 Feb; 62(1):59-76. PubMed ID: 37248373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.
    Marayati R; Stafman LL; Williams AP; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Anderson JC; Willey CD; Beierle EA
    Sci Rep; 2021 Mar; 11(1):5984. PubMed ID: 33727604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma.
    Stafman LL; Mruthyunjayappa S; Waters AM; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Mroczek-Musulman E; Beierle EA
    Oncotarget; 2018 Apr; 9(32):22665-22679. PubMed ID: 29854306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIM447 inhibits oncogenesis and potentiates cisplatin effects in hepatoblastoma.
    Wadhwani N; Markert HR; Marayati R; Bownes LV; Quinn CH; Aye JM; Stewart JE; Yoon KJ; Beierle EA
    J Pediatr Surg; 2021 Jun; 56(6):1157-1164. PubMed ID: 33762119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas.
    Yamada S; Ohira M; Horie H; Ando K; Takayasu H; Suzuki Y; Sugano S; Hirata T; Goto T; Matsunaga T; Hiyama E; Hayashi Y; Ando H; Suita S; Kaneko M; Sasaki F; Hashizume K; Ohnuma N; Nakagawara A
    Oncogene; 2004 Aug; 23(35):5901-11. PubMed ID: 15221005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma.
    Stafman LL; Williams AP; Garner EF; Aye JM; Stewart JE; Yoon KJ; Whelan K; Beierle EA
    Transl Oncol; 2019 Feb; 12(2):200-208. PubMed ID: 30412911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA‑506 participates in pancreatic cancer pathogenesis by targeting PIM3.
    Du J; Zheng X; Cai S; Zhu Z; Tan J; Hu B; Huang Z; Jiao H
    Mol Med Rep; 2015 Oct; 12(4):5121-6. PubMed ID: 26238203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufothionine exerts anti-cancer activities in gastric cancer through Pim3.
    Wang G; Liu G; Ye Y; Fu Y; Zhang X
    Life Sci; 2019 Sep; 232():116615. PubMed ID: 31260686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.
    Pei Y; Yao Q; Yuan S; Xie B; Liu Y; Ye C; Zhuo H
    Oncotarget; 2016 Nov; 7(47):77890-77901. PubMed ID: 27788486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Protein Phosphatase 2A Activation with Novel Tricyclic Sulfonamides on Hepatoblastoma.
    Bownes LV; Julson JR; Quinn CH; Hutchins SC; Erwin MH; Markert HR; Stewart JE; Mroczek-Musulman E; Aye J; Yoon KJ; Ohlmeyer M; Beierle EA
    J Pediatr Surg; 2023 Jun; 58(6):1145-1154. PubMed ID: 36907775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Pim-3 suppresses the tumorigenicity of glioblastoma by regulating cell cycle and apoptosis.
    Quan J; Zhou L; Qu J
    Cell Mol Biol (Noisy-le-grand); 2015 Mar; 61(1):42-50. PubMed ID: 25817345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PIM Kinase Inhibition Attenuates the Malignant Progression of Metastatic Hepatoblastoma.
    Julson JR; Quinn CH; Butey S; Erwin MH; Marayati R; Nazam N; Stewart JE; Beierle EA
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
    Jin J; Jin J; Woodfield SE; Patel RH; Jin NG; Shi Y; Liu B; Sun W; Chen X; Yu Y; Vasudevan SA
    Oncol Rep; 2019 Jan; 41(1):143-153. PubMed ID: 30320362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor GATA4 associates with mesenchymal-like gene expression in human hepatoblastoma cells.
    Soini T; Eloranta K; Pihlajoki M; Kyrönlahti A; Akinrinade O; Andersson N; Lohi J; Pakarinen MP; Wilson DB; Heikinheimo M
    Tumour Biol; 2018 Jul; 40(7):1010428318785498. PubMed ID: 30074440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
    Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
    J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci.
    Kelsey I; Zbinden M; Byles V; Torrence M; Manning BD
    Sci Rep; 2017 Nov; 7(1):16112. PubMed ID: 29170467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.